{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:21:37Z","timestamp":1781612497169,"version":"3.54.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Orthop Relat Res"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Infection of open fractures remains a significant cause of morbidity and mortality to patients worldwide. Early administration of prophylactic antibiotics is known to improve outcomes; however, increasing concern regarding antimicrobial resistance makes finding new compounds for use in such cases a pressing area for further research. CSA-90, a synthetic peptidomimetic compound, has previously demonstrated promising antimicrobial action against <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> in rat open fractures. However, its efficacy against antibiotic-resistant microorganisms, its potential as a therapeutic agent in addition to its prophylactic effects, and its proosteogenic properties all require further investigation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Questions\/purposes<\/jats:title>\n            <jats:p>(1) Does prophylactic treatment with CSA-90 reduce infection rates in a rat open fracture model inoculated with <jats:italic toggle=\"yes\">S aureus<\/jats:italic>, methicillin-resistant <jats:italic toggle=\"yes\">S aureus<\/jats:italic> (MRSA), and methicillin-resistant <jats:italic toggle=\"yes\">Staphylococcus epidermidis<\/jats:italic> (MRSE) as measured by survival, radiographic union, and deep tissue swab cultures? (2) Does CSA-90 reduce infection rates when administered later in the management of an open fracture as measured by survival, radiographic union, and deep tissue swab cultures? (3) Does CSA-90 demonstrate a synergistic proosteogenic effect with bone morphogenetic protein 2 (BMP-2) in a noninfected rat ectopic bone formation assay as assessed by micro-CT bone volume measurement? (4) Can CSA-90 elute and retain its antimicrobial efficacy in vitro when delivered using clinically relevant agents measured using a Kirby-Bauer disc diffusion assay?<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All in vivo studies were approved by the local animal ethics committee. In the open fracture studies, 12-week-old male Wistar rats underwent open midshaft femoral fractures stabilized with a 1.1-mm Kirschner wire and 10 \u00b5g BMP-2 \u00b1 500 \u00b5g CSA-90 was applied to the fracture site using a collagen sponge along with 1 x 10<jats:sup>4<\/jats:sup> colony-forming units of bacteria (<jats:italic toggle=\"yes\">S aureus<\/jats:italic>\/MRSA\/MRSE; n = 10 per group). In the delayed treatment study, d\u00e9bridement and treatment with 500 \u00b5g CSA-90 were performed at Day 1 and Day 5 after injury and bacterial insult (<jats:italic toggle=\"yes\">S aureus<\/jats:italic>). All animals were reviewed daily for signs of local infection and\/or sepsis. An independent, blinded veterinarian reviewed twice-weekly radiographs, and rats showing osteolysis and\/or declining overall health were culled at his instruction. The primary outcome of both fracture studies was fracture infection, incorporating survival, radiographic union, and deep tissue swab cultures. For the ectopic bone formation assay, 0 to 10 \u00b5g BMP-2 and 0 to 500 \u00b5g CSA-90 were delivered on a collagen sponge into bilateral quadriceps muscle pouches of 8-week-old rats (n = 10 per group). Micro-CT quantification of bone volume and descriptive histologic analysis were performed for all in vivo studies. Modified Kirby-Bauer disc diffusion assays were used to quantify antimicrobial activity in vitro using four different delivery methods, including bone cement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Infection was observed in none of the MRSA inoculated open fractures treated with CSA-90 with 10 of 10 deep tissue swab cultures negative at the time of cull. Median survival was 43 days (range, 11-43 days) in the treated group versus 11 days (range, 8-11 days) in the untreated MRSA inoculated group (p &lt; 0.001). However, delayed d\u00e9bridement and treatment of open fractures with CSA-90 at either Day 1 or Day 5 did not prevent infection, resulting in early culls by Day 21 with positive swab cultures (10 of 10 for each time point). Maximal ectopic bone formation was achieved with 500 \u03bcg CSA-90 and 10 \u03bcg BMP-2 (mean volume, 9.58 mm<jats:sup>3<\/jats:sup>; SD, 7.83), creating larger bone nodules than formed with 250 \u03bcg CSA-90 and 10 \u03bcg BMP-2 (mean volume, 1.7 mm<jats:sup>3<\/jats:sup>; SD, 1.07; p &lt; 0.001). Disc diffusion assays showed that CSA-90 could successfully elute from four potential delivery agents including calcium sulphate (mean zone of inhibition, 11.35 mm; SD, 0.957) and bone cement (mean, 4.67 mm; SD, 0.516).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CSA-90 shows antimicrobial action against antibiotic-resistant <jats:italic toggle=\"yes\">Staphylococcal<\/jats:italic> strains in vitro and in an in vivo model of open fracture infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical Relevance<\/jats:title>\n            <jats:p>The antimicrobial properties of CSA-90 combined with further evidence of its proosteogenic potential make it a promising compound to develop further for orthopaedic applications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.blo.0000533624.79802.e1","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T20:07:37Z","timestamp":1524773257000},"page":"1311-1323","source":"Crossref","is-referenced-by-count":14,"title":["CSA-90 Promotes Bone Formation and Mitigates Methicillin-resistant Staphylococcus aureus Infection in a Rat Open Fracture Model"],"prefix":"10.1097","volume":"476","author":[{"given":"Rebecca","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tegan L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Mikulec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Genberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jor.1100020115","article-title":"Production of a standard closed fracture in laboratory animal bone","volume":"2","author":"Bonnarens","year":"1984","journal-title":"J Orthop Res."},{"key":"R2-20230814","first-page":"18","article-title":"Earlier d\u00e9bridement and antibiotic administration decrease infection","volume":"19","author":"Brown","year":"2010","journal-title":"J Surg Orthop Adv"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1128\/AAC.00653-15","article-title":"Bactericidal activity of ceragenin CSA-13 in cell culture and in an animal model of peritoneal infection","volume":"59","author":"Bucki","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s11999-013-2855-4","article-title":"What is the rate of methicillin-resistant Staphylococcus aureus and Gram-negative infections in open fractures?","volume":"471","author":"Chen","year":"2013","journal-title":"Clin Orthop Relat Res."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"208","DOI":"10.22203\/eCM.v026a15","article-title":"A sugar-based phase-transitioning delivery system for bone tissue engineering","volume":"26","author":"Cheng","year":"2013","journal-title":"Eur Cell Mater"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1128\/AAC.00380-10","article-title":"Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins","volume":"54","author":"Epand","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JB.187.7.2426-2438.2005","article-title":"Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain","volume":"187","author":"Gill","year":"2005","journal-title":"J Bacteriol"},{"key":"R8-20230814","article-title":"Antibiotics for preventing infection in open limb fractures","volume":"1","author":"Gosselin","year":"2004","journal-title":"Cochrane Database Syst Rev."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2106\/00004623-199072020-00023","article-title":"The management of open fractures","volume":"72","author":"Gustilo","year":"1990","journal-title":"J Bone Joint Surg Am."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3928\/01477447-20151020-12","article-title":"Acute management of open fractures: an evidence-based review","volume":"38","author":"Halawi","year":"2015","journal-title":"Orthopedics"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ar700270t","article-title":"Ceragenins: cholic acid-based mimics of antimicrobial peptides","volume":"41","author":"Lai","year":"2008","journal-title":"Acc Chem Res."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/jac\/dks434","article-title":"Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections","volume":"68","author":"Leszczynska","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2106\/00004623-200612000-00025","article-title":"Trends in the management of open fractures. A critical analysis","volume":"88","author":"Okike","year":"2006","journal-title":"J Bone Joint Surg Am."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/IAI.00318-08","article-title":"Human host defense peptide LL-37 prevents bacterial biofilm formation","volume":"76","author":"Overhage","year":"2008","journal-title":"Infect Immun"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00003086-198906000-00006","article-title":"Factors influencing infection rate in open fracture wounds","volume":"243","author":"Patzakis","year":"1989","journal-title":"Clin Orthop Relat Res."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1302\/0301-620X.94B1.27026","article-title":"Early antibiotics and d\u00e9bridement independently reduce infection in an open fracture model","volume":"94","author":"Penn-Barwell","year":"2012","journal-title":"J Bone Joint Surg Br."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2106\/JBJS.N.00840","article-title":"Local delivery of the cationic steroid antibiotic CSA-90 enables osseous union in a rat open fracture model of Staphylococcus aureus infection","volume":"97","author":"Schindeler","year":"2015","journal-title":"J Bone Joint Surg Am."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00001432-200306000-00001","article-title":"Community-acquired Staphylococcus aureus infections: increasing virulence and emerging methicillin resistance in the new millennium","volume":"16","author":"Stevens","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/jor.22665","article-title":"Validation of the use of radiographic fracture-healing scores in a small animal model","volume":"32","author":"Tawonsawatruk","year":"2014","journal-title":"J Orthop Res."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.injury.2014.06.025","article-title":"Health outcomes of delayed union and nonunion of femoral and tibial shaft fractures","volume":"45","author":"Tay","year":"2014","journal-title":"Injury"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/TA.0b013e3181a7c16d","article-title":"Development of the radiographic union score for tibial fractures for the assessment of tibial fracture healing after intramedullary fixation","volume":"68","author":"Whelan","year":"2010","journal-title":"J Trauma Acute Care Surg."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/AAC.40.12.2675","article-title":"Antibiotic-impregnated cement and beads for orthopaedic infections","volume":"40","author":"Wininger","year":"1996","journal-title":"Antimicrob Agents Chemother."},{"key":"R23-20230814","first-page":"21","article-title":"Economic burden of illness among US patients experiencing fracture non-union","volume":"5","author":"Wu","year":"2013","journal-title":"Orthop Res Rev."}],"container-title":["Clinical Orthopaedics &amp; Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003086-201806000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T05:11:39Z","timestamp":1691989899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003086-201806000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/01.blo.0000533624.79802.e1","relation":{},"ISSN":["0009-921X"],"issn-type":[{"value":"0009-921X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}